US names first drugs to face price hike penalty
Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases they take that exceed inflation. But they won’t need to pay until 2025.
Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases they take that exceed inflation. But they won’t need to pay until 2025.